Parallel Advisors, LLC Astrazeneca PLC Transaction History
Parallel Advisors, LLC
- $4.31 Billion
- Q1 2025
A detailed history of Parallel Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Parallel Advisors, LLC holds 16,049 shares of AZN stock, worth $1.09 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
16,049
Previous 14,924
7.54%
Holding current value
$1.09 Million
Previous $977,000
20.68%
% of portfolio
0.03%
Previous 0.02%
Shares
36 transactions
Others Institutions Holding AZN
# of Institutions
1,376Shares Held
476MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.1 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$2.79 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.55 Billion0.48% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.63 Billion0.13% of portfolio
-
Franklin Resources Inc San Mateo, CA19.5MShares$1.32 Billion0.37% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $211B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...